Terms ending in 2036
Every in-force patent on GlaxoSmithKline LLC's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,441,787 | Neuromodulation Device In force · High confidence | Galvani Bioelectronics Limited | In force | High confidence | |
| US 10,391,717 | Package and Heat Sealing Device In force · High confidence | Haleon US Holdings LLC | In force | High confidence | |
| US D920,093 | Package In force · High confidence | Haleon UK IP Limited | In force | High confidence | |
| US 12,187,789 | Biopharmaceutical Compositions In force · High confidence | GlaxoSmithKline LLC | In force | High confidence | |
| US 12,187,790 | Biopharmaceutical Compositions In force · High confidence | GlaxoSmithKline LLC | In force | High confidence | |
| US 12,187,791 | Biopharmaceutical Compositions In force · High confidence | GlaxoSmithKline LLC | In force | High confidence | |
| US 10,960,032 | Use of Akkermansia Muciniphila for Treating Inflammatory Conditions In force · Low confidence | Enterobiome Inc. | In force | Low confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by GlaxoSmithKline LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.